Jefferies Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-231,800
Closed -$177M – 1971
2025
Q3
$177M Buy
+231,800
New +$172M 0.83% 17
2024
Q2
– Sell
-400
Closed -$311K – 1668
2024
Q1
$311K Sell
400
-10,700
-96% -$7.61M ﹤0.01% 1203
2023
Q4
$6.47M Sell
11,100
-1,400
-11% -$817K 0.04% 327
2023
Q3
$6.71M Sell
12,500
-23,200
-65% -$12M 0.06% 268
2023
Q2
$16.7M Buy
35,700
+23,200
+186% +$9.7M 0.15% 124
2023
Q1
$4.29M Sell
12,500
-85,000
-87% -$28.7M 0.03% 413
2022
Q4
$35.7M Buy
+97,500
New +$34.6M 0.25% 67

Other funds holding LLY

Jefferies Financial Group's LLY Position: Q3 2026 in Review

Jefferies Financial Group increased its Eli Lilly (LLY) stake by 550% in Q3 2026, buying an estimated $53.5M and bringing the position to 53,598 shares worth $62M. The position accounts for 0.46% of the portfolio, ranked #45.

Jefferies Financial Group first reported a position in LLY in Q1 2016 and has held it in 17 quarters since. The position peaked at $229M in Q3 2025. 4,424 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Jefferies Financial Group held 53,598 shares of Eli Lilly worth $62M as of Q3 2026.
  • Jefferies Financial Group bought 45,348 Eli Lilly shares in Q3 2026, an estimated $53.5M.
  • Eli Lilly made up 0.46% of Jefferies Financial Group's portfolio in Q3 2026, its #45 holding.
  • Jefferies Financial Group first reported a position in Eli Lilly in Q1 2016 and has held it in 17 quarters since.
  • Jefferies Financial Group's Eli Lilly position peaked at $229M in Q3 2025.
  • 4,424 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.